ABSTRACT
OBJECTIVES To investigate the potential of shared sporting equipment as transmission vectors of SARS-CoV-2 during the reintroduction of sports such as soccer, rugby, cricket, tennis, golf and gymnastics.
SETTING Laboratory based live SARS-CoV-2 virus study
INTERVENTIONS Ten different types of sporting equipment were inoculated with 40μl droplets containing clinically relevant high and low concentrations of live SARS-CoV-2 virus. Materials were then swabbed at time points relevant to sports (1, 5, 15, 30, 90 minutes). The amount of live SARS-CoV-2 recovered at each time point was enumerated using viral plaque assays, and viral decay and half-life was estimated through fitting linear models to log transformed data from each material.
MAIN OUTCOME MEASURE The primary outcome measure was quantification of retrievable SARS-CoV-2 virus from each piece of equipment at pre-determined time points.
RESULTS At one minute, SARS-CoV-2 virus was recovered in only seven of the ten types of equipment with the low dose inoculum, one at five minutes and none at 15 minutes. Retrievable virus dropped significantly for all materials tested using the high dose inoculum with mean recovery of virus falling to 0.74% at 1 minute, 0.39% at 15 minutes and 0.003% at 90 minutes. Viral recovery, predicted decay, and half-life varied between materials with porous surfaces limiting virus transmission.
CONCLUSIONS This study shows that there is an exponential reduction in SARS-CoV-2 recoverable from a range of sports equipment after a short time period, and virus is less transferrable from materials such as a tennis ball, red cricket ball and cricket glove. Given this rapid loss of viral load and the fact that transmission requires a significant inoculum to be transferred from equipment to the mucous membranes of another individual it seems unlikely that sports equipment is a major cause for transmission of SARS-CoV-2. These findings have important policy implications in the context of the pandemic and may promote other infection control measures in sports to reduce the risk of SARS-CoV-2 transmission and urge sports equipment manufacturers to identify surfaces that may or may not be likely to retain transferable virus.
WHAT IS ALREADY KNOWN ON THIS TOPIC
WHAT IS ALREADY KNOWN ON THIS TOPIC
Transmission of SARS-CoV-2 between individuals playing sport may be via respiratory droplets when in close proximity to an infected person.
SARS-CoV-2 remains viable on a variety of surfaces resulting in recommendations to reduce the sharing of sports equipment such as tennis balls when sports were re-opened.
WHAT THIS STUDY ADDS
WHAT THIS STUDY ADDS
The recoverable SARS-CoV-2 viral load reduces exponentially with mean viral load of all materials less than 1% of the original inoculum after 1 minute.
The type of material has a significant effect on SARS-CoV-2 transfer, with less virus transferred from porous materials such as bovine leather or nylon woven cloth.
Policies on infection control measures in sport may be better directed towards areas other than reducing the sharing of sports equipment.
Sports equipment manufacturers may consider using materials that absorb or retain virus as a way of reducing viral transmission from sports equipment.
Competing Interest Statement
NSP is employed in part by the England and Wales Cricket Board. All other authors declare no competing interests.
Funding Statement
The study was funded by philanthropic donations and contributions from the UK National Governing Bodies of Sport. The funders had no input into the design, interpretation or reporting of the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This was a laboratory study and required no ethical approval
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available from the authors upon request
